Status:

WITHDRAWN

Pre-Emptive Analgesia in Dental Implant Surgery

Lead Sponsor:

Satheesh Elangovan

Conditions:

Pain, Postoperative

Eligibility:

All Genders

18-64 years

Phase:

EARLY_PHASE1

Brief Summary

To determine the clinical effectiveness of combined use of pre-emptive analgesia and long acting anesthesia for pain suppression following dental implant surgery as measured by a validated numerical r...

Detailed Description

Dental practitioners often prescribe opioids for the relief of moderate - severe acute post-operative pain.1 There is evidence that alternative approaches, such as the use of long acting local anesthe...

Eligibility Criteria

Inclusion

  • Adult patients 18 years of age and under 65 years of age
  • ASA Type I \& II
  • Single tooth edentulous site requiring dental implant placement without any additional bone or soft tissue augmentation at the time of implant placement
  • Patients not requiring use of any form of sedation for dental implant surgery (nitrous, oral or IV sedation)

Exclusion

  • Hypersensitivity to NSAIDs, salicylates, or microcrystalline cellulose NF (Avicel PH 105)
  • Liver disease
  • Renal disease
  • Hypertension and taking angiotensin-converting-enzyme inhibitors and/or diuretics
  • Significant respiratory conditions including acute or severe asthma.
  • Cardiovascular disease that will prevent the patient from going through the surgical procedure or consuming the required medications: cardiac disease, cardiomyopathy, cardiac arrhythmias, coronary heart disease, acute MI, angina, history of MI, coronary artery bypass grafting (CABG), Aspirin intake, peripheral vascular disease, cerebral vascular disease (stroke, TIA)
  • Gastrointestinal disease including irritable bowel disease and gastric ulcers
  • Hematological diseases (coagulopathy, hemophilia or thrombocytopenia)
  • Pregnancy/lactation at the time of surgery
  • Heavy smoking (\>10 cigarettes per day)
  • Diabetes
  • Allergies or intolerance to ibuprofen, opioids, and local anesthetic (lidocaine and bupivacaine)
  • History of recreational drug abuse
  • History of heavy alcohol use. Substance Abuse and Mental Health Services Administration (SAMSHA)30 defines heavy alcohol use as binge drinking on 5 or more days in the past month. SAMSHA defines binge drinking as 5 or more alcoholic drinks for males or 4 or more alcoholic drinks for females on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past month.
  • Patients currently taking prescription pain medications or have taken over-the-counter pain medications within 4 days of surgery.
  • Patients with drug-drug or drug-disease state interactions
  • Other significant medical conditions (not reported above) that are likely to prevent the patient from going through the surgical procedure or consuming the required medications.

Key Trial Info

Start Date :

October 6 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 6 2017

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03243032

Start Date

October 6 2017

End Date

November 6 2017

Last Update

October 12 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Univerity of Iowa College of Dentsitry Dental Clinics

Iowa City, Iowa, United States, 52242